Lymphoma
China leads global CAR-T research with 700+ active trials. Domestic CD19 and BCMA CAR-T products approved at fraction of Western cost.
Treatment Plans for Lymphoma
Compare evidence-based options at top Chinese hospitals — transparent pricing, typical wait, and recovery time.
R-CHOP Chemoimmunotherapy
6-cycle rituximab + CHOP for diffuse large B-cell lymphoma.
CD19 CAR-T Cell Therapy
Autologous CAR-T (relmacabtagene/lis-cel) for relapsed/refractory B-cell lymphoma.
Prices are indicative ranges in USD based on partner hospital published rates. Final quote depends on your medical records and selected hospital — request a free personalized estimate.
Why China for Lymphoma
Domestic CAR-T (axicabtagene biosimilar) at 1/4 Western cost; world-class allo-HSCT programs.
Recommended Hospitals for Lymphoma
Hand-picked by case volume, outcomes, and international patient experience.
Peking Union Medical College Hospital
Tianjin Medical University Cancer Hospital
Sun Yat-Sen University Cancer Center
Ruijin Hospital, Shanghai Jiao Tong University
Peking University Cancer Hospital
Shanghai Cancer Center, Fudan University
Sichuan Cancer Hospital and Institute
About Lymphoma
- Painless lymphadenopathy
- Night sweats
- Fever
- Weight loss (B-symptoms)
- Fatigue
- EBV infection
- HIV/HCV
- Immunosuppression
- Genetic predisposition
- Excisional lymph node biopsy
- PET-CT staging
- Bone marrow biopsy
- Flow cytometry
Evidence & Reference Standards
Our oncology pathways align with internationally recognized cancer-care guidelines:
SSAnkang Health is a medical-tourism coordination service; clinical procedures are performed by JCI-accredited Chinese hospitals. This page is for general information and does not constitute medical advice.